Illumina reagent chemistry kits
Ended Awarded Last action
- Contract number
- 75F40123F19002
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $144,616
Award facts
- Contract value 100% obligated
- $144,615.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$2,358 | |
| Original award | $146,974 |
About this award
The Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits valued at $144,615.89 under a firm fixed-price contract type. The contract was awarded on January 30, 2023, with an ultimate completion date of October 21, 2025, and will be performed in Laurel, Maryland. This delivery order does not utilize a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The reagent chemistry kits procured under this contract support the FDA's laboratory and analytical operations, enabling genetic sequencing and genomic analysis capabilities critical to the agency's mission in pharmaceutical evaluation, biotechnology oversight, and product safety assessment.
Illumina, Inc., a San Diego-based biotechnology company specializing in DNA and RNA sequencing instruments and consumables, is well-positioned as the prime contractor for this procurement. The company maintains an extensive portfolio of federal contracts across civilian agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture, in addition to its work with the FDA. Illumina's reagent kits and sequencing technologies are integral to genomic research, diagnostics, and regulatory testing, making the company a critical supplier of biotechnology solutions across multiple federal departments and laboratories.
Quick answers
Who was awarded contract 75F40123F19002?
75F40123F19002 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on January 30, 2023.
How much is contract 75F40123F19002 worth?
The government has obligated $144,616 on 75F40123F19002.
Is contract 75F40123F19002 an order under another contract?
Yes. 75F40123F19002 is a delivery order under 75F40123D00001, an indefinite delivery contract.
Was contract 75F40123F19002 competed?
The extent of competition for 75F40123F19002 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award